Delivery Order HHSN272201300002I-HHSN27200009
Ended Awarded Last action
- Contract number
- HHSN27200009
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $182,911
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2012138 Solicitation number
- Contract value 100% obligated
- $182,911.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$877 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $2,584 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $91,172 | |
| Original award | $90,032 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The award, with a ceiling value of $182,911.36, is a delivery order issued against ABL's existing Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation. ABL is a leading contract research and manufacturing organization that specializes in developing biologics such as vaccines, monoclonal antibodies, and other infectious disease countermeasures. Under this award, ABL will provide a range of preclinical development and manufacturing services to support NIAID's research initiatives for new vaccines and therapeutics.
Quick answers
Who was awarded contract HHSN27200009?
HHSN27200009 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 28, 2014.
How much is contract HHSN27200009 worth?
The government has obligated $182,911 on HHSN27200009.
Is contract HHSN27200009 an order under another contract?
Yes. HHSN27200009 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract HHSN27200009 competed?
The extent of competition for HHSN27200009 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award